Are oral cancers effectively palliated with radiotherapy? Outcomes of treatment with a modified QUAD SHOT regimen

Saheli Saha,Indranil Mallick,Prattusha Mukherjee,Santam Chakraborty,Tapesh Bhattacharyya,Moses Arunsingh S,Rimpa Basu Achari,Sanjoy Chatterjee
DOI: https://doi.org/10.1002/hed.27730
2024-03-26
Head & Neck
Abstract:Background This study assessed a palliative radiotherapy regimen using daily radiation over 4 days for three courses in inoperable head and neck cancers, emphasizing oral primary cancers. Methods Retrospective data of 116 patients treated with a daily dose of 3.6–3.7 Gy in four fractions over 4 days to a total of three courses, with a 2‐week gap after every course, were analyzed for survival outcomes. A subgroup analysis was done for oral cancer. Results Ninety‐nine (85%) completed three courses. Overall subjective response rate was 77%. Median overall survival and progression‐free survival were 12 months (95% confidence interval [CI]: 8–20) and 8 months (95% CI: 6–10), with numerically higher overall survival in oral cancer. The treatment was well tolerated, with no on‐treatment hospitalization or grade 3–4 toxicities. Conclusion The modified QUAD SHOT regimen is practical for palliation in head and neck cancers.
surgery,otorhinolaryngology
What problem does this paper attempt to address?